N1-(ethyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine | 61695-03-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N1-(ethyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine
• 英文别名: N~1~-Ethyl-N~1~-[(pyridin-2-yl)methyl]ethane-1,2-diamine；N'-ethyl-N'-(pyridin-2-ylmethyl)ethane-1,2-diamine
• CAS: 61695-03-2
• 化学式: C₁₀H₁₇N₃
• 分子量: 179.265
• InChiKey: VSRRJYKJKFZDPL-UHFFFAOYSA-N

物化性质

• 沸点：
  252.4±20.0 °C(Predicted)
• 密度：
  1.018±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Ethoxycarbonyl 4-amino-5-chloro-2-methoxybenzoate 、 N1-(ethyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 4-amino-5-chloro-N-[2-[ethyl(pyridin-2-ylmethyl)amino]ethyl]-2-methoxybenzamide
  参考文献：
  名称：

  Synthesis and neuroleptic activity of benzamides. cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds

  摘要：

  Three series of benzamides of N,N-disubstituted ethylenediamines (linear alkane-1,2-diamines), 1-substituted 2-(aminomethyl)pyrrolidines, and 1-substituted 3-aminopyrrolidines (cyclic alkane-1,2-diamines) were designed and synthesized as potential neuroleptics. All target compounds were evaluated for their inhibitory effects on apomorphine-induced stereotyped behavior in rats, and a good correlation between structure and activity was found throughout the series. In the linear series (analogues of metoclopramide), introduction of a benzyl group on the terminal nitrogen, rather than an ethyl group, and a methyl group on the p-amino group of metoclopramide both enhanced the activity. The resulting N-[2-(N-benzyl-N-methylamino)ethyl]-5-chloro-2-methoxy-4-(methylamino) benzamide(23) was about 15 times more active than metoclopramide. In the cyclic series, particularly among the benzamides of 1-benzyl-3-aminopyrrolidine, most of the compounds tested were more active than the corresponding linear benzamides. cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino) benzamide (YM-09151-2, 55) was the most active among all of the compounds tested, being 13 and 408 times more potent than haloperidol and metoclopramide, respectively. Moreover, compound 55 exhibited a fairly high ratio of antistereotypic activity to cataleptogenicity compared with haloperidol and metoclopramide. It is expected that compound 55 may be used as a potent drug with few side effects in the treatment of psychosis.

  DOI：

  10.1021/jm00142a019
• 作为产物：
  描述：

  (Ethyl-pyridin-2-ylmethyl-amino)-acetonitrile 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 1.0h， 生成 N1-(ethyl)-N1-(2-pyridinylmethyl)-1,2-ethanediamine
  参考文献：
  名称：

  Synthesis and neuroleptic activity of benzamides. cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds

  摘要：

  Three series of benzamides of N,N-disubstituted ethylenediamines (linear alkane-1,2-diamines), 1-substituted 2-(aminomethyl)pyrrolidines, and 1-substituted 3-aminopyrrolidines (cyclic alkane-1,2-diamines) were designed and synthesized as potential neuroleptics. All target compounds were evaluated for their inhibitory effects on apomorphine-induced stereotyped behavior in rats, and a good correlation between structure and activity was found throughout the series. In the linear series (analogues of metoclopramide), introduction of a benzyl group on the terminal nitrogen, rather than an ethyl group, and a methyl group on the p-amino group of metoclopramide both enhanced the activity. The resulting N-[2-(N-benzyl-N-methylamino)ethyl]-5-chloro-2-methoxy-4-(methylamino) benzamide(23) was about 15 times more active than metoclopramide. In the cyclic series, particularly among the benzamides of 1-benzyl-3-aminopyrrolidine, most of the compounds tested were more active than the corresponding linear benzamides. cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino) benzamide (YM-09151-2, 55) was the most active among all of the compounds tested, being 13 and 408 times more potent than haloperidol and metoclopramide, respectively. Moreover, compound 55 exhibited a fairly high ratio of antistereotypic activity to cataleptogenicity compared with haloperidol and metoclopramide. It is expected that compound 55 may be used as a potent drug with few side effects in the treatment of psychosis.

  DOI：

  10.1021/jm00142a019

文献信息

• A Kinetic and Structural Investigation of DNA-Based Asymmetric Catalysis Using First-Generation Ligands
  作者：Fiora Rosati、Arnold J. Boersma、Jaap E. Klijn、Auke Meetsma、Ben L. Feringa、Gerard Roelfes

  DOI：10.1002/chem.200900456

  日期：2009.9.21

  developed concept of DNA‐based asymmetric catalysis involves the transfer of chirality from the DNA double helix in reactions using a noncovalently bound catalyst. To date, two generations of DNA‐based catalysts have been reported that differ in the design of the ligand for the metal. Herein we present a study of the first generation of DNA‐based catalysts, which contain ligands comprising a metal‐binding

  最近开发的基于DNA的不对称催化概念涉及在使用非共价键催化剂的反应中DNA双螺旋的手性转移。迄今为止，已经报道了两代基于DNA的催化剂，其金属配体的设计有所不同。本文中，我们对第一代基于DNA的催化剂进行了研究，其中包含的配体包含通过间隔子与9-氨基ac啶部分相连的金属结合域。特别强调确定DNA对Cu II结构的影响配合物和Diels-Alder催化反应。最重要的发现是DNA的作用仅限于手性支架。在DNA存在下没有观察到速率加速。此外，用于获得高对映选择性的最佳DNA序列已证明包含交替的GC核苷酸。最后，DNA已显示与Cu II配合物相互作用形成手性结构。与带有联吡啶型配体的第二代基于DNA的催化剂的比较显示出明显的差异，据认为与催化剂所处的DNA微环境以及发生反应的位置有关。
• IWANAMI, SUMIO;TAKASHIMA, MUTSUO;HIRATA, YASUFUMI;HASEGAWA, OSAMU;USUDA, +, J. MED. CHEM., 1981, 24, N 10, 1224-1230
  作者：IWANAMI, SUMIO、TAKASHIMA, MUTSUO、HIRATA, YASUFUMI、HASEGAWA, OSAMU、USUDA, +

  DOI：——

  日期：——
• US4097487A
  申请人：——

  公开号：US4097487A

  公开（公告）日：1978-06-27
• US4197243A
  申请人：——

  公开号：US4197243A

  公开（公告）日：1980-04-08